Additional file 3: Table S2. of Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer

作者：Xiaoxue Zhang, Dan Liu, Mengchen Li, Canhui Cao, Dongyi Wan, Bixin Xi, Wei Li, Jiahong Tan, Ji Wang, Zhongcai Wu, Ding Ma, Qinglei Gao · 发表于：Figshare · 年份：2017 · DOI：10.6084/m9.figshare.4580314 · 研究领域：Telomeres, Telomerase, and Senescence、PARP inhibition in cancer therapy、Nuclear Structure and Function

Univariate Cox regression analysis of the clinicopathogical parameters for overall survival and progression free survival. (DOCX 17 kb)